The @Home Opioid Addiction Breakthrough – How Transcutaneous Auricular Neurostimulation and Tele-Thepary offer new weaponry in the fight to cull the Opioid Epidemic

Speaker: Steven Robinson, Jillandra Rovaris

Presenting will be 4 speakers 

 Dr. Jillandra Rovaris –  – CEO of iWELL ’til i’mWELL LLC.   (our parent Company.)

 Dr Diedre Habermehl – Chief Medical Officer – iWILL ’til i’mWELL LLC

 Daniel Wagner – Chief Commercial Officer of Spark Bio-Medical

 Steve Robinson – Chief Operating Officer of iWILL ’til i’mWELL LLC


Short Bio

Dr. Jillandra C. Rovaris

Founder / CEO

iWILL ‘til i’mWELL LLC

A psychologist with more than 35 years of experience working to improve

the mental health of students. Served as Director and Executive Director

for Student Health and Counseling Services at UCSF, Santa Clara, and Tulane Universities.

Taught Psychology at Xavier and Dillard Universities. Taught Freshmen 1st Year Experience at

Tulane University. Served 5 years on the Louisiana Board of Examiners of Psychologists.

Currently serving as Assistant Vice-Chancellor/ Provost – Executive Director of Student Health

Services and Counseling Services (SHCS) at the University of California San Francisco (UCSF)

Subject Matter Expert for the California Board of Psychologists. Practitioner of a “Cura

Personalis” approach to Mental Therapy and Wellness by treating the whole person –

Mind, Body, and Spirit


Steven W. Robinson

Co-Founder/ COO

iWILL ‘til i’mWELL LLC

A globally recognized thought leader in supply chain and operations. He is the former head of

the Global Supply Chain for Walmart, the Former head of Global Logistics for Starbucks, the

Head of the Starbucks Center for Operations Excellence CEO of Air Road, and the former COO

for Gobble Inc. Today, he resides in Silicon valley and advises start-ups in scaling for profitable

growth. He holds a bachelor’s degree in Managerial Economics and Supply Chain Certifications

from Penn State, Texas A&M, and the Lean Institute. He is the 2019 recipient of the Executive

Platforms. Most Innovative Supply Chain award for his work at Gobble Inc. Steve is also the

Chairman/CEO and Founder of “The Supply Chain Project,” a 501 (c ) 3 Non-Profit focusing on

delivering critical services to other non-profits. He is passionate about democratizing mental

health and improving wellness while creating long-term impactful social change with technology


Dr. Deirdre Habermehl

Chief Medical Officer

iWILL ‘til i’mWELL LLC

Dr. Habermehl (“Dr. Dee”) earned her medical degree from New York

University. She then completed an internship at Brown University,

followed by a residency at Stanford University in Palo Alto, California. She also earned her MBA

with a Healthcare Focus at Yale University School of Management. Dr. Habermehl is a,

specialist in Addiction Medicine and is Board Certified in Addiction Medicine, Gynecology, and

Obstetrics. She is a Fellow of the American Society of Addiction Medicine, as well as the

American College of Obstetrics and Gynecology.


Daniel Wagner

Chief Commercial Officer

Spark Biomedical

Dan Wagner is a career Medical Device and Biotechnology Executive

who currently serves Spark Biomedical as Chief Commercial Officer. Based in Dallas, TX, Dan

spent nearly 10 years leading International Sales Operations covering the Americas for

Olympus Corporation, including the merger of Gyrus ACMI and deployment of cutting-edge

technology such as Narrow Band Imaging & Laparo-Endoscopic Single Site surgery. From

there, he has focused on leading early-stage medical technology commercial teams for Heart

Sciences, InLight Medical, and Signature Biologics prior to joining Spark Biomedical. This has

led to tackling Market Access hurdles, successes of wide-spread technology adoption, and

positioning technologies effectively for advanced FDA approval pipelines. Today Dan brings

decades of medical technology experience to the most important task yet – delivering lifesaving

Opioid Withdrawal Symptom management innovation to those in critical need with the team at

Spark Biomedical.


Aug 04 2023


8:00 am - 9:00 am

Leave a Reply